p53 overexpression in head and neck squamous cell carcinoma: Review of the literature

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 3, 1996, Pages 143-149

  Raybaud Diogene H ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Head and neck squamous cell carcinoma; Immunohistochemistry; Oral precancer; p53 tumour suppressor gene

Indexed keywords

PROTEIN P53;

GENE EXPRESSION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; PRECANCER; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0029992926     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00095-X     Document Type: Review

References (67)

1. Boring CC, Squire TS, Tong T. (dancer statistics. CA Cancer J Clin 1992,42, 18-38.
2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54, 4855-4878.
3. Kaur J, Srivastava A, Ralhan R. Overexpression olp53 protein in betel- and tobacco-related human oral dysplasia and squamouscell carcinoma in India. Int J Cancer 1994, 58, 340-345.
4. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 1994, 69, 409-416.
5. Brachman DG, Graves D, Yokes E, el at. Occurrence of p53 gentdeletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992, 52, 4832-4836.
6. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992, 7, 1159-1166.
7. Somers KD, Merrick A, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992, 52, 5997-6000.
8. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993, 53, 4477-4480.
9. Burns JE, Baird MC, Clark LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993, 67, 1274-1284.
10. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL. The role of the p53 tumor suppressor gene in squamous cell carcinoma of head and neck. Arch Otolaryngol Head Neck Surg 1993, 119, 1118-1122.
11. Nées M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993, 53, 4189-4196.
12. Girod SC, Krämer C, Knüfermann R, Krueger GRF. p53 expression in the carcinogenesis in the oral mucosa. J Cell Biochcni 1994, 56,444-448.
13. Frank JL, Bur ME, Garb JL, et al. p53 tumor supressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 1994,73, 181-186.
14. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes Dev 1990, 4, 1-8.
15. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991, 351, 453-456.
16. Lane PD. p53, guardian of the genome. Nature 1992,358, 15-16.
17. Harris CC. p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 1993, 262, 1980-1981.
18. Langdon JD, Partridge M. Expression of the tumor suppressor gene p53 in oral cancer. Br J Oral Maxillofacial Surg 1992, 30, 214-220.
19. Largey JS, Meltzer SJ, Yin J, Norris K, Sauk JJ, Archibald DW. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 1993, 71, 1933-1937.
20. Min BM, Back JH, Shin KH, Gujuluva CN, Chernck HM, Park NH. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Oral Oncol, Eur J Cancer 1994, 30B, 338-345.
21. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991,6, 1785-1789.
22. Caamano J, Zhang SY, Rosvold EA, Bauer B, Klein-Szanto JP. p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am J Pathol 1993, 142, 1131-1139.
23. Wagata T, Shibagaki I, Imamura M, et al. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 1993, 53, 846-850.
24. Yin XY, Smith ML, Whiteside TL, Johnson JT, Herberman RB, Locker J. Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of head and neck. Int J Cancer 1993, 54,322-327.
25. Ranasinghe AW, Warnakulasuriya KAAS, Johnson NW. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Oral Oncol, Eur J Cancer 1993, 29B, 147-150.
26. Sakai E, Tsuchida N. Most human squamous cell carcinomas in
27. the oral cavity contain mutated p53 tumor-suppressor genes. Oncvgcne 1992, 7, 927-933.
28. Huang Y, Meltzer SJ, Yin J, et al. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res 1993, 53, 1889-1894.
29. Chang Y, Lin Y, Tsai C, cl al. Detection of mutations in p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis. Cancer Lclt 1992, 67, 167-174.
30. Sakai E, Rikimaru K, Ueda M, et al. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer 1992, 52, 867-872.
31. Nakanishi Y, Noguchi M, Matsuno Y, Mukai K, Shimosato Y, Hirohashi S. p53 expression in squamous cell carcinoma and dysplasia of the vocal cords and oral cavity. Appl Immimohistochem 1993, 1, 101-107.
32. Zariwala M, Schmid S, Pfaltz M, Ohgaki H, Kleihues P, Schafer R. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymphnode métastases. Im J Cancer 1994, 56, 807-811.
33. Nylander K, Nilsson P, Mehle C, Roos G. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of head and neck. 13r J Cancer 1995, 71, 826-830.
34. Lazarus P, Garewal HS, Sciubba J, et al. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from nontobacco users. Int J Cancer 1995, 60, 458-463.
35. Lane DP. The regulation of p53 function: Steiner award lecture. Int J Cancer 1994, 57, 623-627.
36. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry?-Revisited! J Pathol 1994, 172, 1-4.
37. Nylander K, Stenling R, Gustafsson H, Zackrisson B, Roos G. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 1995, 75, 87-93.
38. Sasano H, Miyazaki S, Gooukon Y, Nishihira T, Sawai T, Nagura H. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992, 23, 1238-1243.
39. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Er J Cancer 1991, 64, 573-577.
40. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63, 1129-1136.
41. Warnakulasuriya KAAS, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992, 21, 404-408.
42. Slootweg PJ, Koole R, Hordijk GJ. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncol, Eur J Cancer 1994, 30B, 138-141.
43. Matthews JB, Scully C, Jovanovic A, Van der Waal I, Yeudall WA, Prime SS. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. Oral Oncol, Eur J Cancer 1993, 29B, 285-289.
44. Sauter ER, Ridge JA, Gordon J, Eisenberg BL. p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base. Am J Surg 1992, 164, 651-653.
45. Shintani S, Yoshihama Y, Emilio AR, Matsumura T. Overexpression of p53 is an early event in the tumorigenesis of oral squamous-cell carcinomas. Anticancer Res 1995, 15, 305-308.
46. Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 1993, 50, 426-429.
47. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 1992, 166, 389-394.
48. Hogmo A, Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G. Nuclear-DNA content and p53 immunostaining in oral squamous-cell carcinoma-an analysis of a consecutive 10-year material. Int J Oncol 1994, 5, 915-920.
49. Shin DM, Kim J, Ro J Y, e t al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994, 54, 321-326.
50. Waiting DL, Gown AM, Coltrera MD. Overexpression of p53 in head and neck cancer. Head Neck 1992, 14, 437-444.
51. Anwar K, Nakakuki K, Imai H, Naiki H, Inuzuka M. Overexpression of p53 protein in human laryngeal carcinoma. hit J Cancer 1993, 53,952-956.
52. Dolcetti R, Doglioni C, Maestro R, et al. p53 overexpression is an early event in the development of human squarnous-cell carcinoma of the larynx: genetic and prognostic implications. lut J Cancer 1992,52, 178-182.
53. Shimaya K, Shiozaki H, Inoue M, et al. Significance of p53 expression as a prognostic factor in oesophageal squarnous cell carcinoma. Virchozvs Archiv A Pathol Anal 1993, 422, 271-276.
54. Wang DY, Xiang YY, Tanaka M, et al. High prevalence of p53 overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 1994, 74, 3089-3096.
55. Helander SD, Peters MS, Pittelkow MR. Expression of p53 protein in benign and malignant epidermal pathologic conditions. J Am Acad Dcrmatol 1993, 29, 741-748.
56. Girod SC, Pape HD, Krueger GRF. p53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa. Oral One,.)/, Eur J Cancer 1994, 30B, 419-423.
57. Sauter ER, Cleveland D, Trock B, Ridge JA, Klein-Szanto AJP. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis 1994, 15, 2269-2274.
58. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 1995, 24, 18-22.
59. Wood MW, Medina JE, Thompson GC, Houck JR, Kyungwhan M. Accumulation of the p53 tumor-suppressor gene-product in oral leukoplakia. Otolaryngol Head Neck Surg 1994,111,758-763.
60. Warnakulasuriya KAAS, Johnson NW. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 1994, 23, 246-250.
61. Burns JE, McFarlane R, Clark LJ, et al. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue. Oral Oncol, EurJ Cancer 1994, 30B, 335-337.
62. Pindborg JJ. Oral Cancer and Precancer. Bristol, John Wright, 1980.
63. Gallo O, Bianchi S. p53 expression: a potential biomarker for risk of muliple primary malignancies in the upper aerodigestivc tract. Oral Oncol, Eur J Cancer 1995, 3IB, 53-57.
64. Chung KY, Mukhopadhyay T, Kirn J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993,53, 1676-1683.
65. Kcmp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993, 74, 813-822.
66. Field JK, Malliri A, Butt SA. p53 overexpression in end stage squamous cell carcinoma of the head and neck: correlates with a very poor clinical outcome. Int J Oncol 1993, 3, 431-435.
67. Gluckman JL, Stambrook PJ, Pavelic ZP. Prognostic significance of p53 protein accumulation in early stage Tl oral cavity cancer. Oral Oncol, EurJ Cancer 1994, 30B, 281.